March 29 - Apr 3, 2019
Georgia World Congress Center
Atlanta, Georgia, USA
Abstract submission deadline: Thursday, November 15
Advance registration deadline: Friday, December 7
Abstract Submission Deadline: Thursday, Nov. 15, 2018Late-Breaking and Clinical Trials Abstract Submission Deadline: Thursday, Jan. 10, 2019
Guidelines for Preparation and Submission of Abstracts
AACR Abstract Submission SystemAuthors must submit abstracts for presentation at the Annual Meeting 2019 using the AACR Abstract Submission System. You can create, modify, and submit abstracts until the
Nov. 15, 2018, abstract deadline.
The Abstract Submission System has been optimized for the
Responsibilities of AuthorsBy submitting an abstract for presentation at the AACR Annual Meeting, abstract authors agree and/or attest to the following:
Content of AbstractsEach abstract should contain: (a) an introductory sentence indicating the purposes of the study; (b) a brief description of pertinent experimental procedures; (c) a summary of the new,
unpublished data; and (d) a statement of the conclusions.
Abstracts should be carefully proofread to avoid errors in the published literature. American spelling should be used
throughout; for more information regarding American spelling, please refer to
Scientific Style and Format: The CSE Manual for Authors, Editors, and Publishers, Eighth Edition (Council of Science
Abstract Control Number An Abstract Control Number (e.g., 18-A-1234-AACR) will be assigned to each abstract submitted online and will be listed on all email correspondence regarding the abstract. Please refer to the Abstract Control Number in any abstract communications.
Top of page
Financial Relationships of CoauthorsPer ACCME regulations, the AACR must collect information on the financial relationships of all meeting presenters and abstract authors. You will be asked to disclose your financial relationships and the financial relationships of all of your coauthors.
Learn more about financial relationships.
Length of AbstractsThe combined length of the abstract body, title, and tables may not exceed 2,600 characters, not including spaces and the author string. Tables count for 800 characters against the limit. Submission cannot be completed for abstracts that exceed this limit.
Abstract Category and SubclassificationYou must select a category and subclassification for your abstract.
View categories and learn more.
Disclosure of Chemical Structures
At the time of abstract submission, the submitting author is required to state whether chemical compounds were used in the scientific work to generate the data in the proffered paper. Chemical compounds are defined as low-molecular-weight (generally <1000 g/mol) organic or inorganic molecules, peptides, or proteins/nucleic acids co-crystallized with low-molecular-weight molecules.
If chemical compounds were used, the corresponding author is further required to indicate whether the complete chemical structures of the compounds used will be disclosed at the time of presentation at the meeting. The chemical structures are not required to be included at the time of abstract submission; rather, an indication of the intent to disclose any such structures at the time of presentation is required.
The Program Committee will then evaluate the information provided by the corresponding author and determine the acceptability of the proffered paper for presentation. Those who do not intend to disclose chemical structures may have their abstracts rejected for participation; however, a limited number of these abstracts may be accepted for presentation if deemed to be of sufficient scientific merit.
Submission FeeEach abstract submitted must be accompanied by a $65 abstract submission fee. The submission fee can be paid by credit card or check. The fee is nonrefundable regardless of the final disposition of the abstract.
Abstract DeadlineThe deadline for abstract submissions is
11:59 p.m. U.S. ET, Thursday, Nov. 15, 2018. Abstracts submitted after the deadline will not be considered by the Program Committee. No changes may be made to abstracts after the Nov. 15, 2018, deadline.
Note: Submitting an abstract for presentation at the AACR Annual Meeting 2019 does not constitute registration for the meeting. Abstract presenters must register to attend the meeting by submitting the registration form or by registering online.
Late-Breaking Abstract Deadline
The deadline for late-breaking abstracts is
11:59 p.m. U.S. ET, Thursday, Jan. 10, 2019. Abstracts detailing highly significant and timely findings in any area of cancer research that were not available at the time of the regular abstract deadline will be considered for presentation at the Annual Meeting. Only those abstracts that are deemed to be of high scientific priority will be accepted.
Abstract submission fees and sponsorship regulations alsoapply to late-breaking abstracts.
Clinical Trials Abstract Deadline
All abstracts describing clinical trials (including placeholder abstracts) should be submitted as late-breaking abstracts. The deadline for clinical trials abstracts is
11:59 p.m. U.S. ET, Thursday, Jan. 10, 2019. Final data for placeholder abstracts are due
Friday, Feb. 1, 2019.
Learn more about how to submit a Clinical Trials Abstract.
Presentation of Proffered Papers at the AACR Annual MeetingEvery proffered abstract that has been accepted for publication in the
Proceedings must have a corresponding presentation at the meeting. Specifically, the author listed as the presenter for an accepted proffered paper must attend the corresponding session to discuss in detail the research outlined in the published abstract, according to the specific guidelines of the session. If, due to unforeseen circumstances, the designated presenter is unavailable to attend the session to present the paper, he or she must contact the AACR Program Development Department to designate a coauthor to serve as the presenter. If no abstract authors are available to present the data, they must withdraw the abstract immediately by contacting the AACR Program Development Department at (215) 440-9300 or
Failure to comply with these regulations pertaining to abstract presentation may result in actions including, but not limited to:
Deadline for Withdrawal of Abstracts
The AACR cannot comply with any request for withdrawal of an abstract that will delay the publication of the
Proceedings. However, requests to withdraw abstracts will be accepted through
Friday, Feb. 1, 2019. Requests to withdraw late-breaking abstracts will be accepted through
Thursday, Feb. 28, 2019. Withdrawal requests must be sent by email to
firstname.lastname@example.org. Withdrawal requests must include the Abstract Control Number and title as well as an explanation of the reason for withdrawal.